Skip to main content

and
  1. No Access

    Article

    Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

    GANEA2 study was designed to assess accuracy and safety of sentinel lymph node (SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients.

    Jean-Marc Classe, Cecile Loaec, P. Gimbergues in Breast Cancer Research and Treatment (2019)

  2. No Access

    Article

    Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer

    To evaluate the therapeutic impact of 18F-fluorocholine (FCH) PET/CT in biochemical recurrent prostate cancer (PC) and to investigate the value of quantitative FCH PET/CT parameters in predicting progression-free...

    M. Colombié, L. Campion, C. Bailly, D. Rusu in European Journal of Nuclear Medicine and M… (2015)

  3. Article

    Open Access

    Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

    En 2006, bevacizumab-FOLFIRI représente la thérapie ciblée administrable dès la première ligne chez les patients porteurs d’un cancer colorectal métastatique non opérable. Une série homogène de 111 patients co...

    J. P. Metges, M. A. Lebot, R. Faroux, F. Riaud, E. Gamelin, O. Capitain in Oncologie (2014)

  4. No Access

    Chapter and Conference Paper

    Qualité de vie après lipomodelage : étude rétrospective à propos de 42 patientes

    Étude de la qualité de vie de 42 patientes ayant bénéficié d’un lipomodelage dans notre institut entre 2009 et 2010.

    J.-F. Le Brun, M. Dejode, J.-M. Classe in Acquis et limites en sénologie / Assets an… (2013)

  5. No Access

    Chapter and Conference Paper

    Le cancer du sein chez l’homme Approche épidémiologique, diagnostique et thérapeutique : étude multicentrique rétrospective à propos de 95 cas

    Analyser les caractéristiques cliniques, histologiques et thérapeutiques de 95 hommes pris en charge pour un cancer du sein entre 2000 et 2010 dans 4 centres hospitaliers et déterminer des facteurs prédictifs ...

    A.-S. Oger, M. Boukerrou, L. Campion in Acquis et limites en sénologie / Assets an… (2013)

  6. No Access

    Article

    Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience

    H Avet-Loiseau, M Roussel, L Campion, X Leleu, G Marit, H Jardel, M Dib in Leukemia (2012)

  7. Article

    Open Access

    Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

    We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The aim of this study was to validate UBE2C protein as a prognostic m...

    D Loussouarn, L Campion, F Leclair, M Campone, C Charbonnel in British Journal of Cancer (2009)

  8. Article

    Open Access

    Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas

    Carcinoma cells lack syndecan-1 expression when they are transiting from an epithelial to a less-differentiated mesenchymal phenotype (epithelial–mesenchymal transition, EMT). Furthermore, a shift of syndecan-...

    D Loussouarn, L Campion, C Sagan, J-S Frenel, F Dravet in British Journal of Cancer (2008)

  9. No Access

    Article

    Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans

    It has recently been suggested that FDG accumulation in the brown adipose tissue varies as a function of age, sex and outdoor temperature. The aim of this study was to assess changes in FDG uptake in brown fat...

    C. Rousseau, E. Bourbouloux, L. Campion in European Journal of Nuclear Medicine and M… (2006)

  10. Article

    Open Access

    G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis

    This study screened large cohorts of node-positive and node-negative breast cancer patients to determine whether the G388R mutation of the FGFR4 gene is a useful prognostic marker for breast cancer as reported by...

    P Jézéquel, L Campion, M-P Joalland, M Millour, F Dravet in British Journal of Cancer (2004)